Navigation Links
National Long Term Care Leaders Praise Senator Snowe's Recognition of Nursing Homes' Unique Funding Challenges in Caring for Nation's Seniors
Date:10/14/2009

Senator Snowe Expresses Concern About Medicare Reimbursement, State Medicaid Budget Crisis

WASHINGTON, Oct. 14 /PRNewswire-USNewswire/ -- Commenting on Maine Senator Olympia Snowe's remarks yesterday recognizing the unique funding challenges faced by the nation's nursing homes in caring for the nation's oldest, most vulnerable citizens, the President and CEO of the American Health Care Association (AHCA), Bruce Yarwood, and the President of the Alliance for Quality Nursing Home Care, Alan G. Rosenbloom, issued the following joint statement:

"The long term care sector's ongoing concern with deep Medicare cuts, in conjunction with the state Medicaid funding crisis fueled by the recession, was reflected in Senator Snowe's comments on the Senate Finance Committee health care reform package. We thank her for focusing much-needed attention on the unique challenges our sector faces in the continued provision of quality care to the vulnerable patients we serve in Maine and across the nation.

"Senator Snowe's specific mention of the Medicare and Medicaid funding issues central to meeting the needs of our patients and workforce represent her recognition of the fragile economic situation in which nursing homes operate, the billions in Medicare cuts already imposed on nursing home care by the Obama Administration, the cuts state Medicaid programs are making to already inadequate nursing home funding, and the fact Medicare and Medicaid funding cannot be viewed in isolation.

"While the long term care community supports health care reform, we will continue to impress upon lawmakers that because three of every four of our nursing home patients' care is funded by Medicare and Medicaid combined - and because facilities devote a full 70% of operating expenses to wages, benefits and other labor costs - adequate Medicare funding levels for nursing home care as part of health reform is integral to staffing stability and qualit
'/>"/>

SOURCE American Health Care Association
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. National Stem Cell Holding, Inc. Discovers Non-Embryonic Biomaterials that Promote Tissue Repair
3. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
4. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
5. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
6. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
7. Public Forum to Discuss Addiction as a Treatable Disease and Highlight National Alcohol and Drug Addiction Recovery Month
8. K-State Researchers Bringing Expertise to Kansas City Symposium on Disease and National Security
9. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
10. September is National Pain Awareness Month
11. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...EWYORK,Nov.25/PRNewswire/--Reportlinker.comannounc...logue: ,, IntranasalDrugDelivery-USMarketTrend...67/Intranasal-Drug-Delivery---US-Market-Trends--An...etiswitnessinganexpansionoftherapeuticapplications...tothedeliveryofsystemictherapeuticdrugs.Thefutureo...
(Date:11/25/2009)...OUNTAINVIEW,Calif.,Nov.25/PRNewswire/-- ChemoCent...fromtheCompany,sPROTECT-1(theProspectiveRandomized...cet-EN(TM)(CCX282-B)inpatientswithmoderate-to-seve...avorablesafetyandtolerabilityprofile.Thestudydemon...iseaseseverityasdefinedasa70-pointdecreaseintheCro...
(Date:11/24/2009)...RVINE,Calif.,Nov.24/PRNewswire-FirstCall/--Endolog...etreatmentsforaorticdisorders,announcedtodaythatit...n,thepatentinfringementlawsuitbroughtagainstitinOc...atesDistrictCourtinIndianapolis,Indiana. ,, End...eUnitedStatesPatentandTrademarkOffice(USPTO)conduc...
Breaking Medicine Technology:Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues 3B Improved Bottom Line 14741 1ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues 3B Improved Bottom Line 14741 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues 3B Improved Bottom Line 14741 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues 3B Improved Bottom Line 14741 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues 3B Improved Bottom Line 14741 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues 3B Improved Bottom Line 14741 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues 3B Improved Bottom Line 14741 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues 3B Improved Bottom Line 14741 8ARKRAY Inc Receives FDA Clearance for New GLUCOCARD 28R 29 Vital 28TM 29 Blood Glucose Monitoring System 6035 1ARKRAY Inc Receives FDA Clearance for New GLUCOCARD 28R 29 Vital 28TM 29 Blood Glucose Monitoring System 6035 2ResMed Inc Announces Record Financial Results for the Quarter Ended September 30 2009 6030 1ResMed Inc Announces Record Financial Results for the Quarter Ended September 30 2009 6030 2ResMed Inc Announces Record Financial Results for the Quarter Ended September 30 2009 6030 3ResMed Inc Announces Record Financial Results for the Quarter Ended September 30 2009 6030 4ResMed Inc Announces Record Financial Results for the Quarter Ended September 30 2009 6030 5ResMed Inc Announces Record Financial Results for the Quarter Ended September 30 2009 6030 6ResMed Inc Announces Record Financial Results for the Quarter Ended September 30 2009 6030 7
...ril 23, 2007 /PRNewswire/ -- Sirion Therapeutics,a...ipeline,compounds, ST-601 (difluprednate) and ST-6...nual meeting of The Association for,Research in Vi...L.,In addition to these presentations, the company... ST-601 (difluprednate) is currently being evaluat...
...alyses To Be Presented --, SAN FRANCISCO, April 24...today announced that data from the Company,s Phase...sease will be,presented for the first time in the ...,s 59th Annual Meeting in Boston on Thursday,May ...l include new,data from both the mild and moderate...
Other Medicine Technology:Sirion Therapeutics Announces Clinical Data to be Presented at the,2007 Association for Research in Vision and Ophthalmology (ARVO),Annual Meeting 2Sirion Therapeutics Announces Clinical Data to be Presented at the,2007 Association for Research in Vision and Ophthalmology (ARVO),Annual Meeting 3Sirion Therapeutics Announces Clinical Data to be Presented at the,2007 Association for Research in Vision and Ophthalmology (ARVO),Annual Meeting 4Medivation Announces First U.S. Presentation of Data From Dimebon,Phase 2 Alzheimer's Disease Trial at American Academy of Neurology,Annual Meeting 2Medivation Announces First U.S. Presentation of Data From Dimebon,Phase 2 Alzheimer's Disease Trial at American Academy of Neurology,Annual Meeting 3
(Date:11/26/2009)... Benton Communications announces a h... system for retailers struggling to make an econom...vember 26, 2009 -- Flu fears is the type of challe...ergency room, according to Dr. David Benton, busin... business growth system – The Rfactor Inten...
(Date:11/25/2009)...SASCITY,Mo.,Nov.25/PRNewswire/--TheBartleHallConve...medicalcliniconDec.9-10,whenKansasCityhoststhelate... ,, "Thisfreecliniceventhasthepotentialtobetheb...ofjustoneandbeheldonweekdaysinsteadofoveraweekend,...lthClinicandpresidentoftheNationalAssociationofFre...
(Date:11/25/2009)...ONTO,Nov.25/PRNewswire/-SentinelleMedicalInc.,alea...zationsoftwarelaunchesasuiteofnewleadingedgeclinic...platformatthisyear,sRadiologicalSocietyofNorthAmer...Booth5800,HallA).Theapplicationsleveragetheuniqueh...MRIimagingcoilsandsupportmultipleimagingmodalities...
(Date:11/25/2009)...ANGELES,Nov.25/PRNewswire-USNewswire/--TheBlackAID...termineexecutiveleadershipfor2010. ,, ThenewBoa...ltiesinpublicpolicy,law,finance,governmenthealthpr...ardalsocomesfromawiderangeofpersonalbackgroundsinc...ivingwithHIVthemselves,andrepresentingmultipleageg...
(Date:11/25/2009)... survivors of testicular cancer who were treated w...ide effects, including neurological side effects a...reated with chemotherapy, according to a new study...he National Cancer Institute . , Marianne Brydy,...iversity Hospital, in Bergen, Norway, and colleagu...
Breaking Medicine News(10 mins):Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Black AIDS Institute Announces 2010 Board Election Results 2
...w scientists are confirming in laboratory studies ...duct collected from beehives--may inhibit the deve...ity of Campinas, Brazil, found that propolis// con...ucrose and promote the binding of cariogenic bacte...
...cording to researchers a new has been found way of... into cartilage that could be used to repair knee ...al of tissue engineering where replacement// or re...pmental pathways - to become more specialised. ...
...ur people are confirmed dead from pneumonic plague... of the plague from a remote village of Himachal P...ptoms of pneumonic plague. // "The sequence o...C.P. Thakur said. "The good news is that the disea...
...male circumcision, or mutilation of the genitals ..., the Middle East and large areas of Africa. Parti...nd religious reasons, but rivals// say that not on...of the tip of the clitoris; Total removal of the c...
...cording to doctors at the research center the radi...sarcoma is an unusual tumour of the bone which is ...r, one case in ten proves resistant to these thera... other treatments and had multiple bone cancer sit...
.... Reddy's Laboratories (DRL) has been slapped with... AAI Pharma Inc for the generic version of the ant...sivity to sell the drug's 40 mg dosage form along ... the patent expiry allows the patent holder to fil...
Other Medicine News:
Qwik-Let® Premier
Finnpipette Techpette Single Channel, 5-50ul
...he range from 2ul to 5000ul. Fills and empties th...advertent volume change. Novel hand grip shape re...lavable at 121C(250F). To prevent corrosion the t...-handed operation. Auto or Normal trigger mode. ...
...om Thermo Labsystems was designed specifically to .... Advanced features such as the new fast dial sys...mes help to define this as a new leader in single ...late offers a custom fit for different hand sizes....
Medicine Products: